Publications
27
Citations
756
Est. group size
~9
Recurring co-author estimate
Active years
26
Publishing since 2001
This publication record appears to span multiple distinct research areas, including medicinal chemistry (developing small-molecule inhibitors like histone deacetylase 6 inhibitors for cancer and Alzheimer's disease), cancer treatment approaches (radiotherapy combined with drugs), and materials science (self-healing polymers for sensors). Given this breadth, the record may reflect contributions from a shared author name across different research groups rather than one continuous research program. Prospective students should verify which specific projects and lab this name refers to at the institution of interest.
Publication output has been irregular over the past decade, with gaps in some years (e.g., 2019, 2021) followed by a notable increase in output from 2024 onward.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Enhancing Self-Healing and Mechanical Robustness through Aluminum Acetylacetonate-Driven Metal–Ligand Coordination for Skin-Inspired Sensing
ACS Applied Polymer Materials · 2024
- Exploit and elucidate chaperone assisted PET hydrolase for upcycling plastics
Chemical Engineering Journal · 2024
- Robust combination of liver stereotactic body radiotherapy modulates pharmacokinetics of sorafenib toward preferable parameters
Scientific Reports · 2020
- Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91]
European Journal of Medicinal Chemistry · 2020
- (<i>N</i>-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma <i>in Vitro</i> and <i>in Vivo</i>
Journal of Medicinal Chemistry · 2018
- 5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer’s Disease Phenotypes
Journal of Medicinal Chemistry · 2018
- Correction: 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition
Organic & Biomolecular Chemistry · 2018
- 1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma
European Journal of Medicinal Chemistry · 2017
- 3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity
European Journal of Medicinal Chemistry · 2016
- Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancer
Scientific Reports · 2016
- European Journal of Medicinal Chemistry×3
- Nature Communications×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Journal of Medicinal Chemistry×2
- Scientific Reports×2
- Jonathan P. Davis
Medicine · The Ohio State University
- Paul M.L. Janssen
Medicine · The Ohio State University
- Jonathan O. Mead
Medicine · The Ohio State University
- Mark T. Ziolo
Medicine · The Ohio State University
- Daniel D. Kinnamon
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile